BiomX Inc.
PHGE · AMEX
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $2 | $1 | $0 | $0 |
| Gross Profit | -$2 | -$1 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $25 | $19 | $16 | $23 |
| G&A Expenses | $12 | $0 | $9 | $11 |
| SG&A Expenses | $12 | $8 | $9 | $11 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $1 | $0 | $2 | $2 |
| Operating Expenses | $37 | $27 | $27 | $35 |
| Operating Income | -$39 | -$28 | -$27 | -$35 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $21 | $2 | -$1 | -$1 |
| Pre-Tax Income | -$18 | -$26 | -$28 | -$36 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$18 | -$26 | -$28 | -$36 |
| % Margin | – | – | – | – |
| EPS | -27.93 | -96.9 | -180.31 | -264.67 |
| % Growth | 71.2% | 46.3% | 31.9% | – |
| EPS Diluted | -27.93 | -96.9 | -180.31 | -264.67 |
| Weighted Avg Shares Out | 4 | 3 | 2 | 1 |
| Weighted Avg Shares Out Dil | 691 | 3 | 2 | 1 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1 | $1 | $1 | $0 |
| Interest Expense | $3 | $2 | $2 | $1 |
| Depreciation & Amortization | $2 | $1 | $3 | $3 |
| EBITDA | -$13 | -$23 | -$24 | -$33 |
| % Margin | – | – | – | – |